NCNury Tatiana Rincón Cuenca

Nury Tatiana Rincón Cuenca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nury Tatiana Rincón Cuenca has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence of chameleons in patients with ischemic stroke: A cross-sectional study

    by Nury Tatiana Rincón Cuenca, Andrés Felipe Herrera Ortiz, Miguel Angel Ruiz, Laura María Camargo, Cesar Alejandro Luzardo Neira, Luisa Fernanda Velasquez Bejarano, Angie Melissa Montoya Caro, Santiago Andrés Monroy Santos, Jaime Eduardo Rodriguez, Carlos Fernando Martinez

    Background: Stroke is a leading cause of mortality and disability worldwide, with timely identification being crucial for effective treatment. However, some patients present as “stroke chameleons” (SC) displaying atypical stroke symptoms that mimic other conditions, often leading to delayed diagnosis and poorer outcomes. This study aims to assess the prevalence and clinical characteristics of SC in a comprehensive stroke center in Colombia. Methods: This cross-sectional study involved ischemic stroke patients admitted to a high-level medical center in Bogotá, Colombia, from January 1, 2021, to December 31, 2023. We identified SC, defined as patients with a confirmed acute stroke in whom a stroke was not initially suspected, as indicated by a negative Cincinnati prehospital stroke scale and no activation of the stroke protocol. We evaluated the proportion of SC, their clinical and imaging characteristics, and compared them with non-SC patients. Results: Among 635 ischemic stroke patients, 78 (12.2%) were identified as SC, while 557 (87.8%) were identified as non-SC. SC exhibited a lower National Institutes of Health stroke scale score and were more likely to present with altered mental status (38% vs. 24%, p = 0.008), dizziness (30% vs. 16%, p = 0.004), and behavioral changes (8% vs. 2%, p = 0.005). SC displayed less middle cerebral artery involvement (24% vs. 56%, p = 0.047) and more multi-territory involvement (34% vs. 17%, p <0.001). In addition, SC had a higher rate of normal computed tomography scans. Conclusion: SC are a significant subset of ischemic strokes, presenting with atypical symptoms that complicate the diagnosis. Recognizing these non-traditional presentations is essential for timely diagnosis, treatment, and potentially improved outcomes.

  • Open Access

    Inflammasomes as a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature

    by Nury Tatiana Rincón Cuenca, Fundación Universitaria de Ciencias de la Salud, Daniela Pereira Lamas, Rosa Fernández Hawa, Ketty Quezada, Luisa García, Pamela Báez, Assma Althobaity, Ngozi Dim, Pontificia Universidad Católica Madre Y Maestra Clínica Unión Médica del Norte

    Introduction: Inflammasomes are multiprotein complexes innate to the immune system that, upon activation, initiate a chain reaction culminating in the production of cytokines IL-1 and IL-18. Recent studies have suggested a connection between inflammasome activation and neurological diseases such as multiple sclerosis (MS). In this review, we aimed to evaluate the role of inflammasomes as potential therapeutic agents and prognostic markers of MS. Methods: Through a database search, 156 articles were identified. Of these, we selected articles focusing on observational and interventional studies that either directly measured the expression of inflammasomes or the levels of cytokines or interleukin as outcomes. After applying a snowball sampling strategy, this review ultimately included nine studies. Results: Our search yielded nine studies published between 2010 and 2022—9 observational studies included case-control and cohort designs. All studies comprised adult populations, 20–72 years of age. All studies incorporated a control group. We selected studies that utilized surrogate measures to evaluate outcomes such as inflammasome expression of NLRP3 or similar genes and assess cytokine levels such as IL-1β, IL-18, IL-23, and TNF. Discussion: Overall, the revised studies suggest a possible role for inflammasomes components, including ASC and caspase-1, which have been evaluated as potential prognostic markers in MS. Therapeutic strategies have focused on the inhibition of NLRP3, which is one of the most prominent and studied inflammasomes, by IFN-β.

  • Open Access

    Prevalence and risk factors of unruptured intracranial aneurysms in ischemic stroke patients – A global meta-analysis

    by Andres Felipe Herrera Ortiz, Enrico Stefano Suriano, Yasmin Eltawil, Manraj Sekhon, Anthony Gebran, Mateo Garland, Nury Tatiana Rincón Cuenca, Tatiana Cadavid, Bassel Almarie

    Background: Unruptured intracranial aneurysms (UIAs) have an estimated global prevalence of 2.8% in the adult population; however, UIA was identified among more than 10% of ischemic stroke patients. Many epidemiological studies and reviews have pointed to the presence of UIA among patients with ischemic stroke; yet, the extent of this association is not fully known. We performed a systematic review and meta-analysis to determine the prevalence of UIA in patients admitted to hospitals with ischemic stroke and transient ischemic attack (TIA) at both global and continental levels and evaluate factors associated with UIA in this population. Methods: We identified, in five databases, all studies describing UIA in ischemic stroke and TIA patients between January 1, 2000, and December 20, 2021. Included studies were of observational and experimental design. Results: Our search yielded 3581 articles of which 23 were included, with a total of 25,420 patients. The pooled prevalence of UIA was 5% (95% confidence interval [CI] = 4–6%) with stratified results showing 6% (95% CI = 4–9%), 6% (95% CI = 5–7%), and 4% (95% CI = 2–5%) in North America, Asia, and Europe, respectively. Significant risk factors were large vessel occlusion (odds ratios [OR] = 1.22, 95% CI = 1.01–1.47) and hypertension (OR = 1.45, 95% CI = 1.24–1.69), while protective factors were male sex (OR = 0.60, 95% CI = 0.53–0.68) and diabetes (OR = 0.82, 95% CI = 0.72–0.95). Conclusion: The prevalence of UIA is notably higher in ischemic stroke patients than the general population. Physicians should be aware of common risk factors in stroke and aneurysm formation for appropriate prevention.


  • Open Access

    Multiple sclerosis with megacystic presentation: A case report

    by Andrés Felipe Herrera Ortiz, Santiago Aristizabal, Juan Guillermo Arámbula, Valeria del Castillo, Juan Calderon, Nury Tatiana Rincón Cuenca, María José Abuchar, María Mónica Yepes, Angela Guarnizo

  • Open Access

    Diagnostic approach to Aicardi syndrome: A case report

    by Nury Tatiana Rincón Cuenca, María Fernanda Castro Peñaranda, Camilo Andres Calderón Valderrama, Santiago Aristizábal Ortiz, Andrés Felipe Herrera Ortiz


  • Open Access

    Computed tomography findings of Crouzon syndrome: A case report

    by Juan Guillermo Arámbula Neira, Valeria del Castillo Herazo, Nury Tatiana Rincón Cuenca, Angélica M. Sanabria Cano, Maryi Fernanda Bermudez Sarmiento, María F. Castro, Andrés Felipe Herrera Ortiz